EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Akumin's enterprise value is $1,513.3 Mil.
Akumin's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $737.7 Mil. Therefore, Akumin's EV-to-Revenue for today is 2.05.
The historical rank and industry rank for Akumin's EV-to-Revenue or its related term are showing as below:
AKUMQ'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.92 Med: 2.86 Max: 6.35
Current: 2.05
During the past 8 years, the highest EV-to-Revenue of Akumin was 6.35. The lowest was 1.92. And the median was 2.86.
AKUMQ's EV-to-Revenue is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 3.02
vs AKUMQ: 2.05
As of today (2024-04-27), Akumin's stock price is $0.375.
Akumin's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $8.17. Therefore, Akumin's PS Ratio for today is 0.05.
Akumin EV-to-Revenue Historical Data
The historical data trend for Akumin's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Akumin's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Akumin's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Akumin's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Akumin's EV-to-Revenue falls into.
Akumin's current Enterprise Value is $1,513.3 Mil.
Akumin's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $737.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akumin's share price for today is $0.375.
Akumin's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.17.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Akumin EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Akumin's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AKUMQ has been successfully added to your 